Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cannabinoids as context-dependent modulators of the adenosine A3 receptors: Potential orthosteric and allosteric mechanisms. | Pharmacol Res | 2026 | 42785538 | PubTator, text mining | PubMed |
| Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes. | J Biol Chem | 2026 | 42660457 | PubTator, text mining | PubMed |
| Correction: Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury. | J Neuroinflammation | 2026 | 42608691 | PubTator, text mining | PubMed |
| 4'-Thionucleosides as adenosine A3 receptor ligands: a medicinal chemistry perspective. | Med Chem Res | 2026 | 42446536 | PubTator, text mining | PubMed |
| From empirical screening to lipid trolling: the evolution of extrahelical allosteric modulators of A1 and A3 adenosine receptors. | Med Chem Res | 2026 | 42446533 | PubTator, text mining | PubMed |
| Neuropathic pain in traumatic brain injury: consequences, mechanisms, and therapeutic avenues. | Inflammopharmacology | 2026 | 42406251 | PubTator, text mining | PubMed |
| A3 Adenosine Receptor Agonists as Multisystem Disease Modifiers: From Molecular Signaling to Clinical Translation. | Biomolecules | 2026 | 42352373 | PubTator, text mining | PubMed |
| Genetic polymorphisms associated with therapeutic response and adverse effects to methotrexate in Taiwanese patients with rheumatoid arthritis: a real-world, hospital-based study. | Sci Rep | 2026 | 42265358 | PubTator, text mining | PubMed |
| Expression of adenosine A1, A2A, A2B, and A3 receptors in ovarian cancer: their clinical potential in diagnosis and prognosis. | Mol Biol Rep | 2026 | 42234312 | PubTator, text mining | PubMed |
| Adenosine receptors in blood cells: Biomarkers and beyond. | Pharmacol Res | 2026 | 42219091 | PubTator, text mining | PubMed |
| Adenosine Receptor Functionality and Desensitization Machinery in a Neuronal Cell Model of Angelman Syndrome. | J Dev Biol | 2026 | 42201242 | PubTator, text mining | PubMed |
| Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer. | J Immunother Cancer | 2026 | 41825935 | PubTator, text mining | PubMed |
| Network toxicology reveals key genes of amiodarone induced pulmonary fibrosis: based on machine learning and SHAP analysis. | Front Pharmacol | 2026 | 41808861 | PubTator, text mining | PubMed |
| De novo purine synthesis reprograms the macrophage inflammatory response and the immune response in sepsis. | Res Sq | 2026 | 41756441 | PubTator, text mining | PubMed |
| Fetal and Neonatal Immune Response to Congenital Cytomegalovirus (cCMV) Infection: A Systematically Conducted Scoping Review. | Viruses | 2026 | 41754585 | PubTator, text mining | PubMed |
| Exploring the Potential of Receptor Silencing in the Tumor Microenvironment by RNA Interference. | Biomolecules | 2026 | 41750383 | PubTator, text mining | PubMed |
| GSCs in the Transdifferentiation Phenomenon: Focus on CAR-T-Based Therapy. | Cells | 2026 | 41744806 | PubTator, text mining | PubMed |
| (N)-Methanocarba Adenosine Derivatives as Dual Modulators of P-Glycoprotein and ABCG2 Transporters. | J Med Chem | 2026 | 41703909 | PubTator, text mining | PubMed |
| Immune modulation in response to coffee intake: a pilot study. | Eur J Nutr | 2026 | 41697370 | PubTator, text mining | PubMed |
| Developments and challenges in hit progression within fragment-based drug discovery. | Nat Commun | 2026 | 41620434 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers